Corporate information
Official name
Concert Pharmaceuticals Incorporated
Registration country
Company type
A biotechnology company creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium.Funding rounds
Series C
( )
Investor | Profile | Country | |
---|---|---|---|
Brookside Capital Partners Management LLC | |||
Flagship Ventures | Venture capital firm | ||
Mediphase Venture Partners | |||
New Leaf Venture Partners (NLV) | |||
Skyline Ventures | Life Sciences venture capital firm | ||
Three Arch Partners LP | Venture capital firm focused on healthcare, medical devices, diagnostics, healthcare services, and biotechnology sectors. | ||
TVM Capital Corp |
Series B
( )
Investor | Profile | Country | |
---|---|---|---|
Brookside Capital Partners Management LLC | |||
Flagship Ventures | Venture capital firm | ||
New Leaf Venture Partners (NLV) | |||
Skyline Ventures | Life Sciences venture capital firm | ||
Three Arch Partners LP | Venture capital firm focused on healthcare, medical devices, diagnostics, healthcare services, and biotechnology sectors. | ||
TVM Capital Corp |
Series A
( )
Investor | Profile | Country | |
---|---|---|---|
Skyline Ventures | Life Sciences venture capital firm | ||
Three Arch Partners LP | Venture capital firm focused on healthcare, medical devices, diagnostics, healthcare services, and biotechnology sectors. | ||
TVM Capital Corp |
Investor | Profile | Country | |
---|---|---|---|
Adage Capital Management | |||
Alexandria Real Estate Equities Inc | |||
Greylock Partners | Venture capital firm. | ||
Hercules Technology Growth Capital Inc | Specialised finance company providing debt and equity growth capital to technology-related companies at all stages of development. | ||
One Liberty Ventures | |||
SR One Ltd | The venture capital unit of GlaxoSmithKline |
Investment activity status
Active investor